MiƱoza, Bonifacia .
HRN: 24-71-98 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/04/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/04/2024
03/10/2024
IV
600mg
Q8
Carbuncle Lumbar Area
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes